HOYA Vision Care, a leader in optical technology innovation, today announced the launch of the MiYOSMART sun range with the global roll-out starting in April 2023 and a planned reach of 30 countries in the following months. The photochromic spectacle lenses,
MiYOSMART Chameleon, and polarised spectacle lenses, MiYOSMART Sunbird, were developed to slow down myopia progression in children using D.I.M.S. Technology, while providing protection from intense sunlight.1-5 These two new products, along with the MiYOSMART clear spectacle lenses which launched in 2018, give children the freedom to comfortably take part in the activities they
enjoy indoors and outdoors without compromising their eyesight.
MiYOSMART Chameleon and MiYOSMART Sunbird both provide protection from intense sunlight, while simultaneously correcting the myopic refractive error and slowing myopia progression.1-5 The new spectacle lenses utilise the same D.I.M.S. Technology used in the award-winning6,7 and non-invasive MiYOSMART clear spectacle lenses, shown to slow myopia progression by 60% in children aged 8 to 13.3 Due to its HOYA photochromic lens technology, MiYOSMART Chameleon is an all- in-one solution to myopia management and protected outdoor activity. It rapidly adapts to the level of sunlight and fades back to clear indoors in seconds.8 Meanwhile, MiYOSMART Sunbird is the ideal addition to MiYOSMART clear spectacle lenses, for extra protection from intense sunlight and
glare.1,9,10 It also offers vibrant colours and rich contrast in bright light, allowing children to fully experience the beauty of outdoors.11
“Children’s vision is worth protecting. By acting today, we give them more opportunity tomorrow,” said Frederiek Ysebaert, Managing Director of the Pediatric Care Business Unit at HOYA Vision Care. “With the launch of MiYOSMART sun spectacle lenses, inspired by our discussions with Eye Care Professionals, we can enable children across the world to spend more time outdoors, while
protecting their eyes from intense sunlight, maximising the benefits of D.I.M.S. Technology on myopia progression.”
Alongside the launch of the MiYOSMART sun range, HOYA Vision Care will launch “protect how they see the world”, a dedicated global campaign to raise awareness of the importance of outdoor time and sun protection in children. Spending time outdoors may slow down myopia progression in children,6,7 and as such it is the most common recommended behavioural management for myopia
given by Eye Care Professionals. 8
However, as the majority of lifetime sun exposure occurs under the age of 21, it is necessary to prevent long-term eye damage to children’s eyes with effective and reliable sun protection. 1,9 This is particularly important for myopic children using atropine eyedropsfor myopia management, and those that are light-sensitive. 2,10,11
From the launch in 2018 until the end of 2022, over 4 million MiYOSMART spectacle lenses were purchased by parents across the world. 18 With the launch of MiYOSMART Chameleon andMiYOSMART Sunbird, HOYA Vision Care will continue to help fight and control the growing problem of myopia around the world.
Product Disclaimer: MiYOSMART spectacle lenses have not been approved for use in the management of Myopia in all countries, including the U.S., and are not currently available for sale in all countries, including the U.S.
# # #
1. WSPOS. Sunlight Exposure & Children’s Eyes Consensus Statement. 2016. Available at:
2. Wu PC, Chuang MN, Choi J, et al. Update in myopia and treatment strategy of atropine use in
myopia control. Eye (Lond). 2019;33(1):3-13.
3. Lam CSY, Tang WC, Tse DY, et al. Defocus Incorporated Multiple Segments (DIMS) spectacle
lenses slow myopia progression: a 2-year randomised clinical trial. Br J Ophthalmol.
4. Lakkis C, Weidemann K. Evaluation of the performance of photochromic spectacle lenses in
children and adolescents aged 10 to 15 years. Clin Exp Optom. 2006;89(4):246-252. .
5. Renzi-Hammond LM, Hammond BR Jr. The effects of photochromic lenses on visual
performance. Clin Exp Optom. 2016;99(6):568-574.
6. Winners of the exhibition’s grand prix. Inventions Geneva. N.D. Available from:
https://inventions-geneva.ch/en/winners/ (Last accessed 28/03/2023)
7. Winners 2020. Silmo Paris. 2020. https://en.silmoparis.com/SILMO-d-OR/SILMO-d-Or-
Awards/2020-Winners# (Last accessed 28/03/2023).
8. Hoya data on file. HOYA Internal Product Performance Validation. 09/2022
9. Hoya data on file. UVA and UVB transmittance for MiYOSMART photochromic and polarized
sun spectacle lenses. 07/2022
10. Hoya data on file. Luminous transmittance for MiYOSMART polarized sun spectacle lenses.
11. Quintana MS, Langa A, del Moral-Martinez I, et al. Polarized Filters Enhance Contrast
Sensitivity When Glare Is Produced On A Flat Surface Under Photopic Conditions. Invest
Ophthalmol Vis Sci. 2006;47(13):1225.
12. Ho CL, Wu WF, Liou YM. Dose-Response Relationship of Outdoor Exposure and Myopia
Indicators: A Systematic Review and Meta-Analysis of Various Research Methods. Int J Environ
Res Public Health. 2019;16(14):2595.
13. Jonas JB, Ang M, Cho P, et al. IMI prevention of myopia and its progression. Invest Ophthalmol
Vis Sci. 2021;62(5):6.
14. WSPOS. Myopia Survey Data. November 2022. Presented as part of WSPOS Symposium:
Comprehensive Update on Myopia Management.19-20 November 2022. Available from:
15. Prevent Blindness. Children’s Eyes are More Susceptible to Long-Term Damage from UV Rays.
2011. Available at: https://preventblindness.org/childrens-eyes-are-more-susceptible-to-long-
term-damage-from-uv-rays/ (Last accessed 28/03/2023)
16. Li FF, Yam JC. Low-Concentration Atropine Eye Drops for Myopia Progression. Asia Pac J
Ophthalmol (Phila). 2019;8(5):360-365.
17. Gong Q, Janowski M, Luo M, et al. Efficacy and Adverse Effects of Atropine in Childhood
Myopia: A Meta-analysis. JAMA Ophthalmol. 2017;135(6):624-630.
18. Based on number of MiYOSMART lenses sold as per Hoya sales data on file as of December
About HOYA Vision Care
For over 60 years, HOYA Vision Care has been a passionate and global leader in optical technology
innovation. As a manufacturer of high quality, high performing eyeglass lenses, HOYA continuously
aims to bring the best possible vision care solutions to Eye Care Professionals and their patients
around the world. The company supplies lenses in 110 countries with a network of over 17,000
employees and 43 laboratories around the globe.
Founded in 1941 in Tokyo, Japan, HOYA Corporation is a global technology and med-tech company
and a leading supplier of innovative high-tech and medical products. HOYA’s divisions and business
units research and develop products utilized in the healthcare and information technology fields. In
the healthcare field, we provide medical device products such as eyeglasses, medical endoscopes,
contact and intraocular lenses, orthopedic implants, surgical/therapeutic devices and medical device
reprocessing and disinfection solutions. In the information technology field, we provide products such
as optical lenses, photomasks and blanks used in the manufacturing process for semiconductor and
LCD/OLED devices, text to speech, human resources and other software solutions and critical
components for the mass memory and cloud storage industries. With over 150 offices and subsidiaries
worldwide, HOYA currently employs a multinational workforce of 37,000 people